HUP0203024A2 - Use of dopamine-d3 receptor agonists for preparation of the compositions available for the therapy of salt-dependent hypertension - Google Patents
Use of dopamine-d3 receptor agonists for preparation of the compositions available for the therapy of salt-dependent hypertensionInfo
- Publication number
- HUP0203024A2 HUP0203024A2 HU0203024A HUP0203024A HUP0203024A2 HU P0203024 A2 HUP0203024 A2 HU P0203024A2 HU 0203024 A HU0203024 A HU 0203024A HU P0203024 A HUP0203024 A HU P0203024A HU P0203024 A2 HUP0203024 A2 HU P0203024A2
- Authority
- HU
- Hungary
- Prior art keywords
- dopamine
- therapy
- salt
- receptor agonists
- preparation
- Prior art date
Links
- 102000004073 Dopamine D3 Receptors Human genes 0.000 title abstract 2
- 108090000525 Dopamine D3 Receptors Proteins 0.000 title abstract 2
- 206010020772 Hypertension Diseases 0.000 title abstract 2
- 230000001419 dependent effect Effects 0.000 title abstract 2
- 229940044601 receptor agonist Drugs 0.000 title abstract 2
- 239000000018 receptor agonist Substances 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 229940087102 Dopamine D3 receptor agonist Drugs 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000002298 dopamine 3 receptor stimulating agent Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A találmány tárgyát a dopamin D3 receptor agonistáknak, előnyösen azR(+)-7-hidroxi-2-(dipropil-amino)-tetralin dopamin D3 receptoragonistának a sófüggő hipertenzió diagnosztizálására és terápiájáraszolgáló gyógyszer gyártására való alkalmazása képezi. ÓThe subject of the invention is the use of dopamine D3 receptor agonists, preferably the dopamine D3 receptor agonist R(+)-7-hydroxy-2-(dipropylamino)-tetralin, for the production of medicine for the diagnosis and therapy of salt-dependent hypertension. HE
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19953254 | 1999-11-04 | ||
| PCT/EP2000/010770 WO2001032263A1 (en) | 1999-11-04 | 2000-10-31 | Use of dopamine-d3 receptor agonists for the therapy of salt-dependent hypertension |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0203024A2 true HUP0203024A2 (en) | 2003-02-28 |
Family
ID=7928007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0203024A HUP0203024A2 (en) | 1999-11-04 | 2000-10-31 | Use of dopamine-d3 receptor agonists for preparation of the compositions available for the therapy of salt-dependent hypertension |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1233815A1 (en) |
| JP (1) | JP2003513053A (en) |
| KR (1) | KR20020062300A (en) |
| CN (1) | CN1387450A (en) |
| AU (1) | AU1390801A (en) |
| BR (1) | BR0015310A (en) |
| CA (1) | CA2389643A1 (en) |
| CZ (1) | CZ20021521A3 (en) |
| HU (1) | HUP0203024A2 (en) |
| IL (1) | IL149266A0 (en) |
| MX (1) | MXPA02004103A (en) |
| NO (1) | NO20022142L (en) |
| RU (1) | RU2002114818A (en) |
| WO (1) | WO2001032263A1 (en) |
| ZA (1) | ZA200204455B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1180599A1 (en) * | 2000-08-16 | 2002-02-20 | Siemens Building Technologies AG | Safeguarding device for a pump, which can be used in a fluid transmission |
| JP2010184889A (en) * | 2009-02-12 | 2010-08-26 | Nihon Univ | Medicine for preventing and treating hypertension |
| BR112012008961A2 (en) * | 2009-10-16 | 2019-09-24 | Epiomed Therapeutics Inc | emesis treatment |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6008219A (en) * | 1995-03-27 | 1999-12-28 | Smithkline Beech P.L.C. | Bicyclic amine derivatives and their use as anti-psychotic agents |
| FR2742149B1 (en) * | 1995-12-11 | 1998-02-13 | Inst Nat Sante Rech Med | NOVEL 2-NAPHTAMIDE DERIVATIVES AND THEIR THERAPEUTIC APPLICATIONS |
-
2000
- 2000-10-31 EP EP00975979A patent/EP1233815A1/en not_active Withdrawn
- 2000-10-31 JP JP2001534466A patent/JP2003513053A/en active Pending
- 2000-10-31 WO PCT/EP2000/010770 patent/WO2001032263A1/en not_active Application Discontinuation
- 2000-10-31 CA CA002389643A patent/CA2389643A1/en not_active Abandoned
- 2000-10-31 IL IL14926600A patent/IL149266A0/en unknown
- 2000-10-31 MX MXPA02004103A patent/MXPA02004103A/en not_active Application Discontinuation
- 2000-10-31 AU AU13908/01A patent/AU1390801A/en not_active Abandoned
- 2000-10-31 CN CN00815203A patent/CN1387450A/en active Pending
- 2000-10-31 BR BR0015310-9A patent/BR0015310A/en not_active Application Discontinuation
- 2000-10-31 HU HU0203024A patent/HUP0203024A2/en unknown
- 2000-10-31 RU RU2002114818/15A patent/RU2002114818A/en not_active Application Discontinuation
- 2000-10-31 CZ CZ20021521A patent/CZ20021521A3/en unknown
- 2000-10-31 KR KR1020027005750A patent/KR20020062300A/en not_active Application Discontinuation
-
2002
- 2002-05-03 NO NO20022142A patent/NO20022142L/en not_active Application Discontinuation
- 2002-06-04 ZA ZA200204455A patent/ZA200204455B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200204455B (en) | 2003-09-04 |
| JP2003513053A (en) | 2003-04-08 |
| CA2389643A1 (en) | 2001-05-10 |
| MXPA02004103A (en) | 2003-08-20 |
| RU2002114818A (en) | 2004-01-10 |
| NO20022142D0 (en) | 2002-05-03 |
| KR20020062300A (en) | 2002-07-25 |
| BR0015310A (en) | 2002-07-09 |
| AU1390801A (en) | 2001-05-14 |
| WO2001032263A1 (en) | 2001-05-10 |
| CZ20021521A3 (en) | 2003-05-14 |
| EP1233815A1 (en) | 2002-08-28 |
| IL149266A0 (en) | 2002-11-10 |
| CN1387450A (en) | 2002-12-25 |
| NO20022142L (en) | 2002-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA28435B1 (en) | INDAZOLE CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS | |
| NO20056132L (en) | Crystalline form of beta2 adrenergic receptor agonist | |
| BRPI0413563A (en) | compounds and compositions as inhibitors of tyrosine kinase receptor activity | |
| DK0760811T3 (en) | Imidazole derivatives as histamine receptor H3 modulators | |
| ATE526318T1 (en) | FARNESOID-X RECEPTOR AGONISTS | |
| DE60214594D1 (en) | SUBSTITUTED PHENYLPROPIONIC ACID DERIVATIVES AS AGONISTS FOR THE HUMAN PEROXISOMPROLIFERATORACTIVATED RECEPTOR ALPHA (PPAR) | |
| MXPA05013364A (en) | Benzazepine derivatives useful for the treatment of 5ht2c receptor associated diseases. | |
| CY1111470T1 (en) | NEW PHARMACEUTICAL COMPOSITIONS CONTAINING FLYVERSERIN POLYMORPH A | |
| HUP0401314A2 (en) | Breath freshening film | |
| BRPI0409910A (en) | Methods for the Treatment of Interleukin-6 Related Diseases | |
| GEP20074078B (en) | Fluoro substituted cyclo-alkanoindoles, compositions comprising them and their use | |
| GEP20094844B (en) | 3-aminocyclopentane carboxamides as modulators of chemokine receptors | |
| CY1107368T1 (en) | NEW 4-Benzylidene-piperidine derivatives | |
| BR0309969A (en) | Use of compounds that are effective as selective opioid receptor modulators | |
| GEP20094843B (en) | 3-aminocyclopentane carboxamides as modulators of chemokine receptors | |
| UY27983A1 (en) | NEW COMPOUNDS OF ISOTIAZOL AND ISOXAZOL AS INHIBITORS OF THE TRANSFORMING GROWTH FACTOR (TGF) | |
| HUP0301122A2 (en) | Pharmaceutical combinations and their use in treating gastrointestinal disorders | |
| RS20070077A (en) | Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflamatory diseases | |
| NO20062088L (en) | Pharmaceutical preparation comprising a selective I1-imidazoline receptor agonist and an angiotensin II receptor blocker | |
| HUP0202399A2 (en) | Use of dopamine d3 receptor ligands for producing pharmaceutical compositions for treating kidney disorders | |
| HUP0203844A2 (en) | Compound with growth hormone releasing properties, pharmaceutical composition containing it and its use | |
| HUP0104647A2 (en) | Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient | |
| BR0015225A (en) | Emphysema treatment using selective retinoid antagonists to rar | |
| MXPA05008960A (en) | Antibacterial indolone oxazolidinones, intermediates for their preparation and pharmaceutical compositions containing them. | |
| TR199700956T1 (en) | Indazole carboxamides. |